{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:00:22Z","timestamp":1791608422581,"version":"4.3.4"},"reference-count":31,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JBM"],"DOI":"10.2147\/jbm.s268907","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T23:55:28Z","timestamp":1602201328000},"page":"345-356","source":"Crossref","is-referenced-by-count":6,"title":["<p>An Open-Label Extension Study to Assess the Long-Term Efficacy and Safety of a Plasma-Derived von Willebrand Factor (VWF)\/Factor VIII (FVIII) Concentrate in Patients with von Willebrand Disease (SWIFT-VWDext Study)<\/p>"],"prefix":"10.2147","volume":"Volume 11","author":[{"given":"Toshko","family":"Lissitchkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3859-7757","authenticated-orcid":true,"given":"Anna","family":"Klukowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Buevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Maltceva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenter","family":"Auerswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8366-5926","authenticated-orcid":true,"given":"Oleksandra","family":"Stasyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1674-1423","authenticated-orcid":true,"given":"Tobias","family":"Rogosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"ref2","volume-title":"Wintrobe\u2019s Clinical Haematology","year":"2008"},{"key":"ref3","first-page":"94","volume":"88","author":"Castaman","year":"2003","journal-title":"Haematologica"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1055\/s-0038-1642471","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMra1601561","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1182\/blood.V97.7.1915","volume":"97","author":"Mannucci","year":"2001","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MBC.0000000000000568","volume":"28","author":"Lissitchkov","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref9","unstructured":"European Medicines Agency. European Public Assessment Report (EPAR). Voncento: human coagulation factor VIII\/von Willebrand factor; 2013. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/voncento-epar-public-assessment-report_en.pdf. Accessed March 18, 2020."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/JBM.S236789","volume":"11","author":"Auerswald","year":"2020","journal-title":"J Blood Med"},{"key":"ref11","unstructured":"ClinicalTrials.gov. Extension study of Biostate in subjects with Von Willebrand Disease (NCT01224808); 2019. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01224808. Accessed March 18, 2020."},{"key":"ref12","unstructured":"European Medicines Agency (EMA). Guideline on the clinical investigation of human plasma derived von Willebrand factor products (CPMP\/BPWG\/220\/02); 2010. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2010\/01\/WC500067126.pdf. Accessed March 18, 2020."},{"key":"ref13","unstructured":"European Medicines Agency (EMA). Guideline on the core SPC for human plasma-derived and recombinant coagulation factor VIII products (CPMP\/BPWG\/1619\/1999); 2007. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-core-spc-human-plasma-derived-recombinant-coagulation-factor-viii-products-revision_en.pdf. Accessed March 18, 2020."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1160\/TH10-10-0631","volume":"105","author":"Windyga","year":"2011","journal-title":"Thromb Haemost"},{"key":"ref15","unstructured":"Octapharma. WILATE\u00ae Summary of Product Characteristics; 2020. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/2873\/smpc. Accessed August 13, 2020."},{"key":"ref16","unstructured":"LFB Biopharmaceuticals. WILLFACT\u00ae Summary of Product Characteristics; 2016. Available from: https:\/\/www.medicines.org.uk\/emc\/medicine\/29947. Accessed March 18, 2020."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.thromres.2014.12.017","volume":"135","author":"Miesbach","year":"2015","journal-title":"Thromb Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1365-2516.2008.01901.x","volume":"15","author":"Berntorp","year":"2009","journal-title":"Haemophilia"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1111\/hae.12497","volume":"21","author":"Khair","year":"2015","journal-title":"Haemophilia"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1111\/jth.14928","volume":"18","author":"Goudemand","year":"2020","journal-title":"J Thromb Haemost"},{"key":"ref21","unstructured":"CSL Behring. VONCENTO\u00ae Summary of Product Characteristics; 2019. Available from: https:\/\/www.medicines.org.uk\/emc\/medicine\/28757. Accessed March 18, 2020."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1111\/j.1365-2516.2012.02758.x","volume":"18","author":"Coppola","year":"2012","journal-title":"Haemophilia"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1055\/s-0037-1613227","volume":"88","author":"Makris","year":"2002","journal-title":"Thromb Haemost"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1055\/s-0037-1613225","volume":"88","author":"Mannucci","year":"2002","journal-title":"Thromb Haemost"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1182\/blood.V99.2.450","volume":"99","author":"Mannucci","year":"2002","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2516.2010.02206.x","volume":"16","author":"Dunkley","year":"2010","journal-title":"Haemophilia"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1160\/TH06-09-0495","volume":"97","author":"Favaloro","year":"2007","journal-title":"Thromb Haemost"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1365-2516.2010.02445.x","volume":"17","author":"Howman","year":"2011","journal-title":"Haemophilia"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1365-2516.2006.01430.x","volume":"13","author":"Shortt","year":"2007","journal-title":"Haemophilia"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1538-7836.2007.02562.x","volume":"5","author":"Borel-Derlon","year":"2007","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Blood Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=62374","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=62374","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T18:44:39Z","timestamp":1723747479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/an-open-label-extension-study-to-assess-the-long-term-efficacy-and-saf-peer-reviewed-article-JBM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":31,"URL":"https:\/\/doi.org\/10.2147\/jbm.s268907","relation":{},"ISSN":["1179-2736"],"issn-type":[{"value":"1179-2736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}